Intranasal drug delivery in neuropsychiatry: focus on intranasal ketamine for refractory depression.
This article examines the advantages and applications of INDD in neuropsychiatry; provides examples of test, experimental, and approved INDD treatments; and focuses especially on the potential of intranasal ketamine for the acute and maintenance therapy of refractory depression.
PMID: 26035196 [PubMed - in process]
Source: Journal of Clinical Psychiatry - Category: Psychiatry Tags: J Clin Psychiatry Source Type: research
More News: Autism | Brain | Chronic Pain | Depression | Gastroenterology | Headache | Migraine | Neurology | Pain | Parkinson's Disease | Psychiatry | Schizophrenia | Social Anxiety Disorder